Trevi Therapeutics, Inc.

Q1 2023 13F Holders

Symbol
TRVI
CUSIP
89532M101
Type
Equity
Class
COM
Num filers
37
Total reported value, excl. options
$80.4M
Manager Report Date Value ($000) Shares